Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
2.
Hum Exp Toxicol ; 37(9): 983-990, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29249184

RESUMEN

The incidence of nonalcoholic fatty liver disease (NAFLD) is considered a risk factor for hepatic fibrosis. Therefore, there is critical need to develop novel cheap and effective therapeutic approaches to prevent and reverse NAFLD. Caffeine is commonly consumed beverage and has antioxidant and anti-inflammatory activities. This study examined whether caffeine can ameliorate liver injury induced by high-fat diet (HFD) feeding. Four groups of rats were used and treated for 16 weeks as follows: control group, rats were fed a standard diet; HFD group, rats were fed HFD; and caffeine 20 and caffeine 30 groups, rats were fed HFD for 16 weeks in addition to different doses of caffeine (20 or 30 mg/kg, respectively) for last 8 weeks. The HFD-induced liver injury is determined biochemically by evaluating serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, bilirubin, triglycerides, cholesterol, and high-density lipoprotein-cholesterol and by histopathological examination. Tissue malondialdehyde, total nitrate/nitrite, and glutathione concentration were also measured. Real-time reverse transcription polymerase chain reaction technique was used to determine the expression of lipogenic enzyme genes. Caffeine treatment significantly decreased the elevated serum ALT, AST, and bilirubin and increased the reduced albumin level. Interestingly, the hepatic mRNA expression of Fatty acid synthase and acetyl CoA carboxylase was decreased by caffeine, while the protein expression of hepatic carnitine palmitoyltransferase 1 and proliferation-activated receptor α was increased. Furthermore, caffeine reduced tissue lipid peroxidation and oxidative stress. These effects suggest that caffeine could improve HFD-induced hepatic injury by suppressing inflammatory response and oxidative stress and regulating hepatic de novo lipogenesis and ß-oxidation.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Cafeína/farmacología , Dieta Alta en Grasa , Hígado/efectos de los fármacos , Enfermedad del Hígado Graso no Alcohólico/prevención & control , Estrés Oxidativo/efectos de los fármacos , Animales , Biomarcadores/sangre , Citoprotección , Modelos Animales de Enfermedad , Regulación Enzimológica de la Expresión Génica , Peroxidación de Lípido/efectos de los fármacos , Lipogénesis/efectos de los fármacos , Lipogénesis/genética , Hígado/metabolismo , Hígado/patología , Masculino , Enfermedad del Hígado Graso no Alcohólico/genética , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Enfermedad del Hígado Graso no Alcohólico/patología , Oxidación-Reducción , Ratas Wistar
4.
Niger J Med ; 18(2): 172-4, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19630323

RESUMEN

BACKGROUND: Secondary amyloidosis of the conjunctiva and respiratory mucosal antedating cancer is very rare. We present a case illustrating this rare association in order to draw the attention of clinician to the association between secondary amyloidosis and cancers. METHOD: We present a 72-yrs-old woman with secondary amyloidosis of conjunctiva and the mucosa of the nasal and para-nasal sinuses secondary to renal cell carcinoma a common medical masquerader. She presented with bleeding fleshy growth on the conjunctivae and in the nostrils and the para nasal sinuses. She also had a left renal mass. The histology of the conjunctivae and mucosa lesions revealed secondary amyloid deposit in the tissues. While the renal biopsy tissue showed papillary renal cell carcinoma. CONCLUSION: We suggest therefore, that secondary amyloidosis including those of rare sites should be suspected in patients with chronic inflammations and malignancies. And it is also pertinent to look for malignancy in cases of unexplained reactive amyloid.


Asunto(s)
Amiloidosis/etiología , Carcinoma de Células Renales/complicaciones , Enfermedades de la Conjuntiva/etiología , Neoplasias Renales/complicaciones , Mucosa Nasal , Enfermedades Nasales/etiología , Enfermedades de los Senos Paranasales/etiología , Síndromes Paraneoplásicos/etiología , Anciano , Amiloidosis/diagnóstico , Amiloidosis/terapia , Femenino , Humanos
5.
J Physiol Biochem ; 65(3): 225-33, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20119817

RESUMEN

This study aimed to investigate whether treatments with vitamin E, L-carnitine and melatonin can protect against CCl(4) and diabetes-induced hepatic oxidative stress. Hepatic oxidative stress was performed in rats through 50% v/v carbon tetrachloride (CCl(4)) (1 ml/kg/3 days, i.p.), and through diabetes mellitus induced by streptozotocin (STZ) (40 mg/kg, i.p.). Vitamin E (100 mg/kg/day, i.p), L-carnitine (300 mg/kg/day, i.p.) and melatonin (10 mg/kg/day, i.p.) were injected for a period of 6 weeks. Thereafter, changes in serum glucose level, liver function tests, hepatic malondialdehyde (MDA) content, hepatic reduced glutathione (GSH) content, hepatic superoxide dismutase (SOD) activity, and serum total antioxidant capacity (TAC) level were evaluated. In CCl(4)-induced liver fibrosis, the efficacy order was melatonin > L-carnitine > vitamin E, while in STZ-induced diabetes, the efficacy order was vitamin E > or = melatonin > L-carnitine. In conclusion, these data indicate that low dose of melatonin is more effective than high doses of vitamin E and L-carnitine in reducing hepatic oxidative stress induced by CCl(4) and diabetes. Moreover, the potent effect of vitamin E in ameliorating diabetes can be linked not only to the antioxidant actions, but also to the superior effect in reducing diabetes-induced hyperglycaemia. Meanwhile, potency of L-carnitine was nearly the same in CCl(4) and diabetes-induced liver damage.


Asunto(s)
Intoxicación por Tetracloruro de Carbono/tratamiento farmacológico , Carnitina/farmacología , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Melatonina/farmacología , Vitamina E/farmacología , Animales , Antioxidantes/metabolismo , Glucemia/metabolismo , Intoxicación por Tetracloruro de Carbono/complicaciones , Intoxicación por Tetracloruro de Carbono/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Diabetes Mellitus Experimental/metabolismo , Glutatión/metabolismo , Masculino , Malondialdehído/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo
6.
Niger J Med ; 18(4): 422-3, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-20120151

RESUMEN

Thrombotic thrombocytopenic purpura (TTP) is an uncommon and potentially fatal syndrome which is due to either congenital or acquired deficiency of the ultra large von Willbrand's factor (ULVWF) cleavage protease. It is characterized by mechanical micro angiopathic hemolytic anemia, and organ dysfunctions.


Asunto(s)
Diabetes Mellitus Tipo 2/complicaciones , Endocarditis Bacteriana/complicaciones , Forunculosis/complicaciones , Púrpura Trombocitopénica Trombótica/etiología , Infecciones Estafilocócicas/complicaciones , Diagnóstico Diferencial , Endocarditis Bacteriana/diagnóstico , Forunculosis/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Púrpura Trombocitopénica Trombótica/diagnóstico , Infecciones Estafilocócicas/diagnóstico
7.
West Indian Med J ; 56(2): 178-81, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17910151

RESUMEN

Tuberous sclerosis complex manifests predominantly as a neurocutaneous disorder Lung involvement was considered rare. Lymphangioleiomyomatosis which occurs mainly in women of childbearing age is the major pulmonary disorder seen in tuberous sclerosis. Multifocal micronodular pneumocyte hyperplasia has also been described in tuberous sclerosis. The case of a 51-year old female diagnosed with tuberous sclerosis is described after she presented with progressive shortness of breath and was found to have interstitial lung disease. Tuberous sclerosis should be considered as a differential in patients with interstitial lung disease especially in association with cutaneous lesions.


Asunto(s)
Hiperplasia/patología , Enfermedades Pulmonares/etiología , Pulmón/patología , Esclerosis Tuberosa/patología , Dolor en el Pecho/diagnóstico , Progresión de la Enfermedad , Disnea/diagnóstico , Femenino , Humanos , Hiperplasia/diagnóstico , Enfermedades Pulmonares/diagnóstico , Enfermedades Pulmonares/patología , Persona de Mediana Edad , Enfermedades de la Piel/etiología , Esclerosis Tuberosa/complicaciones , Esclerosis Tuberosa/diagnóstico
8.
West Indian med. j ; 56(2): 178-181, Mar. 2007. ilus
Artículo en Inglés | LILACS | ID: lil-476409

RESUMEN

Tuberous sclerosis complex manifests predominantly as a neurocutaneous disorder Lung involvement was considered rare. Lymphangioleiomyomatosis which occurs mainly in women of childbearing age is the major pulmonary disorder seen in tuberous sclerosis. Multifocal micronodular pneumocyte hyperplasia has also been described in tuberous sclerosis. The case of a 51-year old female diagnosed with tuberous sclerosis is described after she presented with progressive shortness of breath and was found to have interstitial lung disease. Tuberous sclerosis should be considered as a differential in patients with interstitial lung disease especially in association with cutaneous lesions.


El complejo de esclerosis tuberosa se manifiesta predominantemente como un desorden neurocutáneo. El compromiso pulmonar era considerado raro. La linfangioleiomiomatosis que se presenta principalmente en mujeres en estado de gestación, es el principal trastorno observado en la esclerosis tuberosa. La hiperplasia micronodular pneumocítica ha sido también descrita en la esclerosis tuberosa. Se describe el caso de una mujer de 51 años a quien se le diagnosticó esclerosis tuberosa, luego de que se presentara con disnea y se hallara que padecía la enfermedad intersticial del pulmón. La esclerosis tuberosa deber ser considerada como un diagnóstico diferencial en pacientes con la enfermedad intersticial del pulmón, especialmente cuando se encuentra asociada con lesiones cutáneas.


Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Esclerosis Tuberosa/patología , Hiperplasia/patología , Enfermedades Pulmonares/etiología , Pulmón/patología , Enfermedades de la Piel , Progresión de la Enfermedad , Disnea/diagnóstico , Dolor en el Pecho/diagnóstico , Esclerosis Tuberosa/complicaciones , Esclerosis Tuberosa/diagnóstico , Hiperplasia/diagnóstico , Enfermedades Pulmonares/diagnóstico , Enfermedades Pulmonares/patología
9.
West Indian Med J ; 54(3): 210-2, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16209229

RESUMEN

The colon responds monomorphically to a variety of insults thus making it difficult to differentiate invasive amoebic colitis and inflammatory bowel disease (IBD). The authors present a case with chronic dysentery, haematochezia, anaemia and hypoproteinaemia. The endoscopic findings were suggestive of IBD. The stool examination was negative for trophozoites or cysts of parasites. The recto-colonic biopsy specimens showed mucosal inflammation with exudates containing amoebic trophozoites. The patient was successfully treated with metronidazole and iodoquinol. He recovered within two weeks and repeat colonoscopy four weeks after the treatment showed a normal rectum and colon. Clinicians should have a high level of suspicion for amoebic colitis in cases of colitis especially in regions where amoebiasis is still present. Efforts should be made to find the amoebic trophozoites in multiple stool and colonic biopsy specimens.


Asunto(s)
Disentería Amebiana/diagnóstico , Adulto , Amebicidas/uso terapéutico , Diagnóstico Diferencial , Quimioterapia Combinada , Disentería Amebiana/tratamiento farmacológico , Humanos , Enfermedades Inflamatorias del Intestino/diagnóstico , Yodoquinol/uso terapéutico , Masculino , Metronidazol/uso terapéutico
10.
West Indian med. j ; 54(3): 210-212, Jun. 2005.
Artículo en Inglés | LILACS | ID: lil-417392

RESUMEN

The colon responds monomorphically to a variety of insults thus making it difficult to differentiate invasive amoebic colitis and inflammatory bowel disease (IBD). The authors present a case with chronic dysentery, haematochezia, anaemia and hypoproteinaemia. The endoscopic findings were suggestive of IBD. The stool examination was negative for trophozoites or cysts of parasites. The recto-colonic biopsy specimens showed mucosal inflammation with exudates containing amoebic trophozoites. The patient was successfully treated with metronidazole and iodoquinol. He recovered within two weeks and repeat colonoscopy four weeks after the treatment showed a normal rectum and colon. Clinicians should have a high level of suspicion for amoebic colitis in cases of colitis especially in regions where amoebiasis is still present. Efforts should be made to find the amoebic trophozoites in multiple stool and colonic biopsy specimens


El colon responde de manera monomórfica a una variedad de insultos, lo cual hace difícil distinguir entre la colitis amebiana invasiva y la enfermedad intestinal inflamatoria (EII). Los autores presentan un caso con disentería crónica, hematoquexia, anemia e hipoproteinemia. Los resultados endoscópicos apuntaban a una EII. El análisis de las heces fecales arrojó resultados negativos en cuanto a presencia de trofozoitos o quistes de parásitos. Esto condujo a un diagnóstico erróneo y el paciente fue tratado por una EII. Sin embargo, los especímenes de la biopsia rectocolónica mostraron una inflamación mucosal con exudados en los que se hallaban presentes trofozoitos amebianos. El paciente tuvo un tratamiento exitoso con metronidazol y iodoquinol. Se recuperó en dos semanas, y se le repitió la colonoscopia cuatro semanas después de que el tratamiento mostró un recto y colon normales. Los clínicos debían mostrar un alto nivel de sospecha ante la colitis amebiana, especialmente en aquellas regiones donde la amebiasis todavía está presente. Deben hacerse esfuerzos por encontrar trofozoitos amebianos en múltiples especímenes de heces fecales y biopsia colónica.


Asunto(s)
Humanos , Masculino , Adulto , Disentería Amebiana/diagnóstico , Amebicidas/uso terapéutico , Diagnóstico Diferencial , Disentería Amebiana/tratamiento farmacológico , Enfermedades Inflamatorias del Intestino/diagnóstico , Yodoquinol/uso terapéutico , Metronidazol/uso terapéutico , Quimioterapia Combinada
12.
West Indian Med J ; 53(1): 47-9, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15114895

RESUMEN

This paper reports the case of a 21-year-old Afro-Caribbean pregnant woman with hyperthyroidism and hypokalaemic quadriparesis and reviews the literature on the topic. Thyrotoxic periodic paralysis is a very rare condition in the Caribbean. This case reminds West Indian physicians to consider this rare condition in any patient that presents with paralysis.


Asunto(s)
Hipopotasemia/etiología , Parálisis/etiología , Complicaciones del Embarazo/diagnóstico , Tirotoxicosis/complicaciones , Adulto , Antitiroideos/uso terapéutico , Población Negra , Carbimazol/uso terapéutico , Femenino , Humanos , Hipopotasemia/tratamiento farmacológico , Potasio/uso terapéutico , Embarazo , Complicaciones del Embarazo/tratamiento farmacológico , Tirotoxicosis/diagnóstico , Tirotoxicosis/tratamiento farmacológico
13.
West Indian med. j ; 53(1): 47-49, Jan. 2004.
Artículo en Inglés | LILACS | ID: lil-410562

RESUMEN

This paper reports the case of a 21-year-old Afro-Caribbean pregnant woman with hyperthyroidism and hypokalaemic quadriparesis and reviews the literature on the topic. Thyrotoxic periodic paralysis is a very rare condition in the Caribbean. This case reminds West Indian physicians to consider this rare condition in any patient that presents with paralysis


Asunto(s)
Humanos , Femenino , Embarazo , Adulto , Tirotoxicosis , Complicaciones del Embarazo/diagnóstico , Hipopotasemia/etiología , Parálisis/etiología , Antitiroideos , Tirotoxicosis , Población Negra , Carbimazol/uso terapéutico , Complicaciones del Embarazo/tratamiento farmacológico , Hipopotasemia/tratamiento farmacológico , Potasio/uso terapéutico
16.
Niger Postgrad Med J ; 8(3): 148-9, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11721213

RESUMEN

A 37 year old hide and skin trader in Northern Nigeria, presented with massive right sided purulent pleural effusion. This started with cough, chest pain and fever for 5 weeks following endotracheal intubation. He had chest tube inserted and was treated with antituberculous drugs for 10 weeks without improvement. Fungal studies on the sputum, and pleural fluid yielded Blastomycetes dermatitidis which responded excellently to ketoconazole and saline pleural lavage. This experience underscores the need for early suspicion of systemic mycosis in suspected cases of tuberculosis with poor or no response to treatment. This will reduce morbidity, mortality and cost of treatment.


Asunto(s)
Blastomicosis/diagnóstico , Derrame Pleural/diagnóstico , Derrame Pleural/microbiología , Adulto , Antifúngicos/uso terapéutico , Blastomicosis/tratamiento farmacológico , Blastomicosis/microbiología , Humanos , Enfermedades Pulmonares Fúngicas/diagnóstico , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/microbiología , Masculino , Nigeria , Derrame Pleural/tratamiento farmacológico , Resultado del Tratamiento
17.
World J Surg ; 24(3): 365-71, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10658074

RESUMEN

Open (OC) or laparoscopic (LC) cholecystectomy is considered a relative contraindication in patients with liver cirrhosis. The effect of LC and OC on the hepatic catabolic stress response was studied in patients with postnecrotic liver cirrhosis and chronic hepatitis to define the most suitable procedure from a metabolic point of view. Altogether 14 patients with cirrhosis and 14 with chronic hepatitis were randomized to LC or OC (n = 7 in each group). The increase in the functional hepatic nitrogen clearance (FHNC) was quantified. Changes in glucose, insulin, glucagon, cortisol, epinephrine, norepinephrine, and prostaglandin E(2) (PGE(2)) were observed. There was no difference in FHNC between LC and OC in any of the patients. Among cirrhotic patients OC caused a 132% increase in FHNC (p < 0.05) and among the hepatitis patients a 69% increase (p < 0.05). In contrast, there was no significant increase following LC in any of the patients. OC increased fasting glucose and insulin in the hepatitis patients (p < 0.01 and p < 0.001, respectively) and in the cirrhosis group (p < 0.01 and p < 0.05, respectively). Alanine stimulation increased glucose in hepatitis patients after OC (p < 0.05) and after LC (p < 0.01). Stimulated glucagon increased after OC in the hepatitis group (p < 0.05). During stimulation cortisol was higher following LC in hepatitis patients (p < 0.01) and cirrhotic patients (p < 0.05). Fasting PGE(2) was down-regulated after LC in hepatitis patients (p < 0.05) and cirrhotic patients (p < 0.01) and after OC in the hepatitis group (p < 0.001). FHNC is similar after LC and OC. Thus from a metabolic point of view, LC has no advantage over OC.


Asunto(s)
Colecistectomía/métodos , Colelitiasis/cirugía , Hepatitis C Crónica/complicaciones , Cirrosis Hepática/complicaciones , Hígado/metabolismo , Estrés Fisiológico/metabolismo , Colecistectomía Laparoscópica , Colelitiasis/complicaciones , Femenino , Hepatitis C Crónica/metabolismo , Humanos , Cirrosis Hepática/metabolismo , Pruebas de Función Hepática , Masculino , Persona de Mediana Edad , Nitrógeno/metabolismo , Estadísticas no Paramétricas
18.
Curr Med Res Opin ; 16(3): 184-9, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11191008

RESUMEN

This is an open trial investigating the efficacy and metabolic effects of 3 months' treatment with lacidipine in 25 Nigerian Africans with mild to moderate hypertension. There was a significant fall in sitting diastolic blood pressure, with treatment (p = 0.01). There were no significant weight changes. The heart rate initially rose significantly with the drug but this normalised with time. All biochemical and haematological indices remained essentially unchanged during therapy. Lacidipine therefore proved an efficacious and metabolically neutral antihypertensive in mild to moderate hypertension in Africa.


Asunto(s)
Antihipertensivos/uso terapéutico , Población Negra , Dihidropiridinas/uso terapéutico , Hipertensión/tratamiento farmacológico , Antihipertensivos/farmacología , Seguridad de Productos para el Consumidor , Dihidropiridinas/farmacología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nigeria
19.
Dig Surg ; 16(6): 471-7, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10805546

RESUMEN

BACKGROUND: As impaired immune function observed in cirrhotic patients is known to increase the risk of postoperative complications, the immunological response to surgery was investigated. METHODS: Twenty-eight patients with postnecrotic liver cirrhosis or chronic hepatitis C and symptomatic gallstone disease were randomly allocated to laparoscopic (LC) or open cholecystectomy (OC). Changes in concentrations of cytokines (TNF-alpha, IL-1beta, IL-6, IL-8 and IL-10) were followed and the effect of surgical trauma on the distribution of lymphocyte subpopulations (CD3, CD4, CD8, CD16 and CD19) and NK cell cytotoxicity were measured. RESULTS: After OC a decrease in circulating CD3 (p < 0.05) and CD4 (p < 0.05) and an increase in CD19 (p < 0.05) cells were detected in contrast to LC after which only CD16 cells decreased (p = 0.05). The number of CD3 cells was higher after LC than after OC (p < 0.01), whereas the number of CD19 cells was higher after OC than after LC (p < 0.01). NK cell cytotoxicity was reduced after LC (p < 0.05). In cirrhotic patients circulating cytokines were unaffected by OC, whereas TNF-alpha (p < 0.05) and IL-1beta (p < 0.05) were reduced after LC. In chronic hepatitis IL-1beta decreased after OC (p = 0.05) and IL-10 was significantly higher after LC than following OC (p < 0.05). CONCLUSION: The immune response is less pronounced after a laparoscopic procedure compared to a conventional approach in patients with chronic liver disease.


Asunto(s)
Formación de Anticuerpos/inmunología , Colecistectomía Laparoscópica , Colecistectomía , Colelitiasis/cirugía , Hepatitis B Crónica/inmunología , Hepatitis C Crónica/inmunología , Inmunidad Celular/inmunología , Cirrosis Hepática/inmunología , Complicaciones Posoperatorias/inmunología , Adulto , Colelitiasis/inmunología , Citocinas/sangre , Citotoxicidad Inmunológica/inmunología , Femenino , Humanos , Tolerancia Inmunológica/inmunología , Células Asesinas Naturales/inmunología , Subgrupos Linfocitarios/inmunología , Masculino , Persona de Mediana Edad
20.
West Afr J Med ; 17(1): 42-6, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9643160

RESUMEN

In the treatment of hypertension, some patients may go off control while still on the drugs. This occurs especially with sympathetic inhibitors and vasodilators. Lacidipine, a new calcium antagonist acts principally by vasodilatation. After a wash out period, patients with mild to moderate hypertension received 4 mg of Lacidipine for two weeks. After evaluation at two weeks, those uncontrolled received 6 mg of Lacidipine, while those controlled continued with 4 mg of Lacidipine for another two weeks. By the next evaluation, while patients continued whatever doses they were on, any one who had gone off control had 25 mg of Hydrochlorothiazide added. They were evaluated finally after another two weeks. It was found in this study that 91.3% (21/23) were controlled by the end with only Lacidipine either in 4 mg or 6 mg doses. Another 8.7% (2/23) initially controlled on Lacidipine went off control while still on the drug, and were eventually controlled by adding Hydrochlorothiazide. Some transient side effects not warranting discontinuation were encountered. It is concluded that Lacidipine is effective as monotherapy in mildly to moderately hypertensive Nigerian Africans; with good tolerance and safety profile. Where transient control is encountered, addition of a diuretic could be beneficial.


Asunto(s)
Antihipertensivos/uso terapéutico , Bloqueadores de los Canales de Calcio/uso terapéutico , Dihidropiridinas/uso terapéutico , Hidroclorotiazida/uso terapéutico , Hipertensión/tratamiento farmacológico , Adulto , Anciano , Población Negra , Quimioterapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nigeria , Índice de Severidad de la Enfermedad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...